Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
JP Stock MarketDetailed Quotes
9470 Gakken Holdings
- 998
- -8-0.80%
20min DelayNot Open Jan 9 15:30 JST
44.54BMarket Cap18.97P/E (Static)
1012High995Low175.00KVolume1012Open1006Pre Close174.98MTurnover108252wk High0.63%Turnover Ratio44.63MShares90452wk Low52.6EPS TTM27.92BFloat Cap1975Historical High18.97P/E (Static)27.97MShs Float200Historical Low52.6EPS LYR1.69%Amplitude25.00Dividend TTM0.81P/B100Lot Size2.51%Div YieldTTM
Gakken Holdings Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 13.07%185.57B | 18.13%50.76B | 11.88%42.75B | 5.18%164.12B | 14.69%44.76B | 2.16%38.19B | 0.52%42.97B | 3.58%38.21B | 3.60%156.03B | 5.19%39.02B |
| Cost of revenue | 15.53%135.67B | 17.83%35.32B | 14.86%31.69B | 7.14%117.43B | 18.33%31.82B | 3.44%28.04B | 0.99%29.98B | 6.42%27.59B | 3.95%109.61B | 1.45%26.89B |
| Gross profit | 6.87%49.9B | 18.84%15.44B | 4.15%11.06B | 0.57%46.69B | 6.64%12.93B | -1.21%10.15B | -0.57%12.99B | -3.13%10.62B | 2.80%46.43B | 14.54%12.13B |
| Operating expense | 6.17%43.02B | 7.36%11.13B | 2.09%10.22B | 1.30%40.52B | -3.97%10.07B | 2.59%10.07B | 3.05%10.37B | 3.90%10.01B | 2.76%40B | -0.92%10.49B |
| Operating profit | 11.51%6.88B | 64.27%4.3B | 38.35%837M | -4.00%6.17B | 74.41%2.86B | -82.00%83M | -12.70%2.62B | -54.31%605M | 3.01%6.43B | 32,720.00%1.64B |
| Net non-operating interest income (expenses) | -43.41%-294M | -62.79%-70M | -65.91%-73M | -21.30%-205M | -50.00%-72M | -12.20%-46M | 0.00%-43M | -18.92%-44M | -3.05%-169M | -17.07%-48M |
| Non-operating interest income | 60.00%32M | 166.67%8M | 400.00%5M | 100.00%20M | --8M | 166.67%8M | 0.00%3M | -75.00%1M | -33.33%10M | --0 |
| Non-operating interest expense | 44.89%326M | 69.57%78M | 73.33%78M | 25.70%225M | 66.67%80M | 22.73%54M | 0.00%46M | 9.76%45M | 0.00%179M | 9.09%48M |
| Net investment income | 48.72%174M | 140.00%12M | -2.00%49M | -40.00%117M | 240.00%17M | -66.17%45M | 25.00%5M | -5.66%50M | 2.09%195M | -16.67%5M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -42.03%-882M | 96.49%-22M | -998M | -305.63%-621M | -128.14%-56M | 62M | -6,866.67%-627M | 0 | 39.81%302M | -10.76%199M |
| Income from associates and other participating interests | -50.72%171M | -159.02%-144M | 465.63%234M | 14.14%347M | -27.42%180M | -144.83%-13M | 17.31%244M | 64.64%-64M | 187.61%304M | 1,871.43%248M |
| Special income (charges) | -145.47%-386M | -308.51%-192M | -108M | 207.88%849M | 232.39%932M | -125.00%-36M | 41.25%-47M | 0 | -137.05%-787M | -200.85%-704M |
| Less:Restructuring and mergern&acquisition | --0 | ---- | ---- | ---741M | ---- | ---- | ---- | ---- | --0 | ---- |
| Less:Other special charges | 191.47%193M | --132M | --93M | -331.87%-211M | -3,737.50%-291M | 112.50%34M | ---- | ---- | -77.59%91M | -95.65%8M |
| Less:Write off | 87.38%193M | 5,900.00%60M | --15M | -85.20%103M | -85.63%100M | --2M | --1M | --0 | 179.52%696M | 1,292.00%696M |
| Other non-operating income (expenses) | -161.70%-29M | 123.81%20M | 29.17%-17M | -72.83%47M | -95.89%3M | 261.90%152M | -202.44%-84M | 0.00%-24M | -17.22%173M | 135.48%73M |
| Income before tax | -15.97%5.63B | 88.75%3.91B | -114.84%-77M | 4.03%6.71B | 173.16%3.87B | -59.41%246M | -34.55%2.07B | -58.71%519M | 7.24%6.45B | 6,256.52%1.42B |
| Income tax | -5.09%2.93B | 92.63%1.96B | -112.65%-32M | 3.52%3.09B | 88.97%1.54B | -8.08%273M | -22.95%1.02B | -53.75%253M | -11.07%2.98B | 236.45%816M |
| Net income | -25.23%2.71B | 84.93%1.95B | -116.92%-45M | 4.44%3.62B | 287.67%2.33B | -109.06%-28M | -42.85%1.06B | -62.54%266M | 30.31%3.47B | 4.17%600M |
| Net income continuous operations | -25.25%2.71B | 85.02%1.95B | -116.92%-45M | 4.47%3.62B | 287.67%2.33B | -108.74%-27M | -42.85%1.06B | -62.54%266M | 30.31%3.47B | 4.35%600M |
| Noncontrolling interests | 4.71%445M | 183.67%139M | -118.18%-6M | 1,670.83%425M | 4,650.00%285M | 544.44%58M | 2,350.00%49M | 371.43%33M | -42.86%24M | 200.00%6M |
| Net income attributable to the company | -29.24%2.26B | 79.92%1.81B | -116.38%-38M | -7.15%3.19B | 244.18%2.04B | -128.24%-85M | -45.44%1.01B | -66.95%232M | 31.45%3.44B | 3.31%593M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -29.24%2.26B | 79.92%1.81B | -116.38%-38M | -7.15%3.19B | 244.18%2.04B | -128.24%-85M | -45.44%1.01B | -66.95%232M | 31.45%3.44B | 3.31%593M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -26.92%52.99 | 83.95%42.07 | -116.67%-0.88 | -7.83%72.51 | 243.29%46.31 | -128.72%-1.95 | -45.87%22.87 | -67.29%5.28 | 21.87%78.67 | 3.61%13.49 |
| Diluted earnings per share | -26.84%52.6 | 85.66%42.07 | -116.79%-0.88 | -7.76%71.9 | 243.53%45.93 | -128.93%-1.95 | -45.87%22.66 | -67.21%5.24 | 22.04%77.95 | 3.72%13.37 |
| Dividend per share | 0.00%25 | 0.00%12.5 | 0 | 4.17%25 | 4.17%12.5 | 0 | 4.17%12.5 | 0 | 9.09%24 | 9.09%12 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |